FLECAINIDE ACETATE (flecainide acetate) by Humanwell Pharmaceutical is clinical pharmacology flecainide acetate tablets, usp have local anesthetic activity and belong to the membrane stabilizing (class 1) group of antiarrhythmic agents; they have electrophysiologic effects characteristic of the ic class of antiarrhythmics. Approved for — paroxysmal supraventricular tachycardias (psvt), including atrioventricular nodal reentrant tachycardia, atrioventricular reentrant tachycardia and 3 more indications. First approved in 2020.
Drug data last refreshed 22h ago
CLINICAL PHARMACOLOGY Flecainide acetate tablets, USP have local anesthetic activity and belong to the membrane stabilizing (Class 1) group of antiarrhythmic agents; they have electrophysiologic effects characteristic of the IC class of antiarrhythmics. Electrophysiology In man, flecainide acetate…
Worked on FLECAINIDE ACETATE at Humanwell Pharmaceutical? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.